The rationale and use of topiramate for treating neuropathic pain

被引:68
作者
Chong, MS
Libretto, SE
机构
[1] Kings Coll Hosp London, London SE5 9AZ, England
[2] Medway Hosp NHS Trust, Gillingham, England
[3] Janssen Cilag Ltd, High Wycombe, Bucks, England
关键词
neuropathic pain; topiramate; treatment;
D O I
10.1097/00002508-200301000-00008
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To outline the modes of action of topiramate and to examine the theoretical reasons as to why topiramate may alleviate neuropathic pain. Results of animal and human studies in the use of topiramate for treating pain are reviewed, together with case studies describing Situations where topiramate was effective when other treatments have failed. Conclusions: Topiramate acts on neuronal transmission in at least five ways: by modulating voltage-gated sodium ion channels, potentiating gamma-aminobutric acid inhibition, blocking excitatory glutamate neurotransmission, modulating voltage-gated calcium ion channels. and by inhibiting carbonic anhydrase. This review suggests that there are good theoretical reasons for a trial of topiramate in patients with neuropathic pain where conventional medical treatments have failed. Although not currently licensed for treating pain. topiramate should be considered before invasive methods of pain relief are contemplated, Most of the side effects of topiramate are dose dependent, but by starting medication with a low dose (less than or equal to 25 mg/d) that is gradually titrated upward tolerance is much more easily achieved.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 63 条
  • [1] AVOLI M, 1996, EPILEPSIA S4, V37, P51
  • [2] Avoli Massimo, 1997, Epilepsia, V38, P44
  • [3] Topiramate relieves refractory intercostal neuralgia
    Bajwa, ZH
    Sami, N
    Warfield, CA
    Wootton, J
    [J]. NEUROLOGY, 1999, 52 (09) : 1917 - 1917
  • [4] Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243
  • [5] NEUROGENIC PAIN SYNDROMES AND THEIR MANAGEMENT
    BOWSHER, D
    [J]. BRITISH MEDICAL BULLETIN, 1991, 47 (03) : 644 - 666
  • [6] AMPA/kainate receptor antagonists as novel analgesic agents
    Brennan, TJ
    [J]. ANESTHESIOLOGY, 1998, 89 (05) : 1049 - 1051
  • [7] Brown SD, 1993, EPILEPSIA S2, V34, P122
  • [8] PROTEIN-KINASE-C REDUCES MG2+ BLOCK OF NMDA-RECEPTOR CHANNELS AS A MECHANISM OF MODULATION
    CHEN, L
    HUANG, LYM
    [J]. NATURE, 1992, 356 (6369) : 521 - 523
  • [9] CONNOR GS, 2000, M AM PAIN SOC ATL GA
  • [10] CONTI F, 1999, SHAPING EXCITATION G, P451